1. Home
  2. DVA vs HMY Comparison

DVA vs HMY Comparison

Compare DVA & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • HMY
  • Stock Information
  • Founded
  • DVA 1994
  • HMY 1950
  • Country
  • DVA United States
  • HMY South Africa
  • Employees
  • DVA N/A
  • HMY N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • HMY Precious Metals
  • Sector
  • DVA Health Care
  • HMY Basic Materials
  • Exchange
  • DVA Nasdaq
  • HMY Nasdaq
  • Market Cap
  • DVA 9.7B
  • HMY 9.4B
  • IPO Year
  • DVA 1995
  • HMY N/A
  • Fundamental
  • Price
  • DVA $130.10
  • HMY $14.99
  • Analyst Decision
  • DVA Hold
  • HMY Hold
  • Analyst Count
  • DVA 3
  • HMY 2
  • Target Price
  • DVA $154.67
  • HMY $12.20
  • AVG Volume (30 Days)
  • DVA 663.6K
  • HMY 6.7M
  • Earning Date
  • DVA 10-28-2025
  • HMY 01-01-0001
  • Dividend Yield
  • DVA N/A
  • HMY 0.92%
  • EPS Growth
  • DVA 8.72
  • HMY 67.74
  • EPS
  • DVA 10.20
  • HMY 1.29
  • Revenue
  • DVA $13,161,328,000.00
  • HMY $4,161,584,110.00
  • Revenue This Year
  • DVA $5.96
  • HMY $25.83
  • Revenue Next Year
  • DVA $3.54
  • HMY $0.96
  • P/E Ratio
  • DVA $12.76
  • HMY $11.56
  • Revenue Growth
  • DVA 5.09
  • HMY 20.39
  • 52 Week Low
  • DVA $126.07
  • HMY $7.97
  • 52 Week High
  • DVA $179.60
  • HMY $18.77
  • Technical
  • Relative Strength Index (RSI)
  • DVA 38.72
  • HMY 51.40
  • Support Level
  • DVA $131.77
  • HMY $14.73
  • Resistance Level
  • DVA $137.58
  • HMY $15.50
  • Average True Range (ATR)
  • DVA 2.61
  • HMY 0.57
  • MACD
  • DVA -0.54
  • HMY 0.06
  • Stochastic Oscillator
  • DVA 4.45
  • HMY 80.33

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Share on Social Networks: